16 participants
A Phase 2 Study Of Zanzalintinib For Patients With Recurrent Or Metastatic Olfactory Neuroblastoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-12
- Start Date:
- 2026-10-01
- Completion:
- 2028-07-01
Conditions
- Metastatic Olfactory Neuroblastoma
Interventions
- DRUG
No Results Yet